📝 usncan Note: Sell HIMS Stock Ahead of Its Earnings?
Disclaimer: This content has been prepared based on currently trending topics to increase your awareness.
CHONGQING, CHINA – JULY 30: In this photo illustration, a person holds a smartphone displaying the logo of Hims & Hers Health Inc. (NYSE: HIMS), an American telehealth company offering personal care products and online healthcare services, with the company’s branding visible in the background, on July 30, 2025 in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)
Getty Images
Hims & Hers Health (NYSE:HIMS) is set to announce its earnings on Monday, August 4, 2025. Historically, HIMS stock has reacted unfavorably to earnings announcements. Since 2021, the stock has recorded a negative one-day return in 53% of instances after results. The median one-day decline has amounted to -5.8%, with a maximum one-day decrease of -22.3%.
For traders focused on events, grasping these historical trends can be beneficial. While the actual results compared to consensus and expectations will be vital, there are two main strategies to contemplate:
- Pre-Earnings Positioning: Assess the historical probabilities and take a position prior to the earnings announcement.
- Post-Earnings Positioning: Investigate the relationship between immediate and medium-term returns after the earnings are released to inform your positioning.
Analysts expect HIMS to report earnings of $0.23 per share on revenues of $552 million. This would mark substantial growth compared to the same quarter last year, which recorded earnings of $0.16 per share on revenues of $315 million. A possible positive factor for Hims & Hers’ sales growth momentum is the reported underperformance of Novo Nordisk’s weight loss medication in the U.S. due to the presence of compounded versions.
Regarding fundamentals, HIMS has a market capitalization of $15 billion. Over the past twelve months, the company generated $1.8 billion in revenue and was operationally profitable, reporting $110 million in operating profits and a net income of $164 million.
However, if you’re looking for upside with less volatility than individual stocks, the Trefis High Quality portfolio offers an alternative — it has outperformed the S&P 500 and achieved returns exceeding 91% since its inception. Additionally, see – Is There More Upside For MSFT Stock?
Review earnings reaction history of all stocks
HIMS Stock Historical Likelihood of Positive Post-Earnings Return
Here are some insights on one-day (1D) post-earnings returns:
- There are 17 earnings data points collected over the last five years, with 8 positive and 9 negative one-day (1D) returns documented. In summary, positive 1D returns were recorded approximately 47% of the time.
- This percentage rises to 50% when considering data from the last 3 years instead of 5.
- The median of the 8 positive returns = 15%, while the median of the 9 negative returns = -5.8%
Additional information regarding the observed 5-Day (5D) and 21-Day (21D) returns post earnings is summarized along with the statistics in the table below.
HIMS 1D, 5D, and 21D Post Earnings Return
Trefis
HIMS Stock Correlation Between 1D, 5D, and 21D Historical Returns
A comparatively lower-risk strategy (though not effective if the correlation is weak) is to understand the relationship between short-term and medium-term returns post earnings, identify a pair that has the highest correlation, and perform the corresponding trade. For instance, if 1D and 5D exhibit the highest correlation, a trader can take a “long” position for the next 5 days if the 1D post-earnings return is positive. Here is some correlation information based on a 5-year and 3-year (more recent) timeframe. Note that the correlation 1D_5D denotes the relationship between 1D post-earnings returns and subsequent 5D returns.
HIMS Correlation Between 1D, 5D and 21D Historical Returns
Trefis
Discover more about the Trefis RV strategy that has outperformed its all-cap stocks benchmark (a blend of the S&P 500, S&P mid-cap, and Russell 2000), delivering strong results for investors. Additionally, if you seek upside with a smoother experience than an individual stock like Hims & Hers Health, consider the High Quality portfolio, which has surpassed the S&P and yielded >91% returns since its inception.
